Co-Diagnostics Inc
NASDAQ:CODX

Watchlist Manager
Co-Diagnostics Inc Logo
Co-Diagnostics Inc
NASDAQ:CODX
Watchlist
Price: 1.24 USD 2.48%
Market Cap: 39.6m USD
Have any thoughts about
Co-Diagnostics Inc?
Write Note

Co-Diagnostics Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Co-Diagnostics Inc
Capital Expenditures Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Co-Diagnostics Inc
NASDAQ:CODX
Capital Expenditures
-$1.2m
CAGR 3-Years
-9%
CAGR 5-Years
-72%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Capital Expenditures
-$723m
CAGR 3-Years
8%
CAGR 5-Years
4%
CAGR 10-Years
-2%
Boston Scientific Corp
NYSE:BSX
Capital Expenditures
-$780m
CAGR 3-Years
-15%
CAGR 5-Years
-8%
CAGR 10-Years
-10%
Stryker Corp
NYSE:SYK
Capital Expenditures
-$634m
CAGR 3-Years
-9%
CAGR 5-Years
-1%
CAGR 10-Years
-11%
Abbott Laboratories
NYSE:ABT
Capital Expenditures
-$2.2B
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Capital Expenditures
-$1.2B
CAGR 3-Years
-67%
CAGR 5-Years
-29%
CAGR 10-Years
-33%

See Also

What is Co-Diagnostics Inc's Capital Expenditures?
Capital Expenditures
-1.2m USD

Based on the financial report for Jun 30, 2024, Co-Diagnostics Inc's Capital Expenditures amounts to -1.2m USD.

What is Co-Diagnostics Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-72%

Over the last year, the Capital Expenditures growth was -1%. The average annual Capital Expenditures growth rates for Co-Diagnostics Inc have been -9% over the past three years , -72% over the past five years .

Back to Top